The clinical samples we collected were all primary untyped treated sample tissues, so the low level of CD8+PD1+ T cells infiltration in the tumor parenchyma of the MMP11 positive expression group may suggest poor efficacy of ICIs. The gene discussed is CD8A; the disease is neoplasm.